共 304 条
- [1] Adams SM(2013)Ulcerative colitis American Family Physician. 87 699-705
- [2] Bornemann PH(2016)Therapeutic targets in inflammatory bowel disease: current and future American Journal of Gastroenterology Supplements. 3 27-37
- [3] Bilsborough J(2017)Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Lancet (London, England). 390 2769-2778
- [4] Targan SR(2017)Current and emerging therapeutic targets for IBD Nature Reviews. Gastroenterology & Hepatology. 14 269-278
- [5] Snapper SB(2012)Phyto-chemical and pharmacological applications of Berberis aristata Fitoterapia. 83 817-830
- [6] Ng SC(2018)Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis International Immunopharmacology. 57 121-131
- [7] Shi HY(2018)Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon Frontiers in Pharmacology. 9 571-599
- [8] Hamidi N(2016)Berberine and inflammatory bowel disease: a concise review Pharmacological Research. 113 592-214
- [9] Underwood FE(2020)Berberine for diarrhea in children and adults: a systematic review and meta-analysis Therapeutic Advances in Gastroenterology. 13 1-19-194
- [10] Tang W(2019)Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease International Journal of Pharmaceutics. 558 201-2329